Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pfizer May Be Regaining Appetite For Large M&A; Is Bristol On The Menu?

Executive Summary

Pfizer appears to be more open to large-scale mergers and acquisitions than it has been in recent years, comments by Vice Chairman David Shedlarz suggest

You may also be interested in...



Bristol Extends Interim CEO Cornelius’ Reign, But Acquisition Rumors Persist

The appointment of James Cornelius as Bristol-Myers Squibb's permanent CEO may be a de facto extension of his tenure as interim chief executive of the firm

Bristol Extends Interim CEO Cornelius’ Reign, But Acquisition Rumors Persist

The appointment of James Cornelius as Bristol-Myers Squibb's permanent CEO may be a de facto extension of his tenure as interim chief executive of the firm

Pfizer Cost-Cutting: Details Are Sketchy, But Sales Force Is On The Table

Pfizer CEO Jeffrey Kindler has opened the door to sales force reductions as part of the firm's latest cost-cutting initiative, announced Oct. 1

UsernamePublicRestriction

Register

PS047580

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel